Syk kinase silencer (ZaBeCor)

N/A

Report date: 2022/02/07 17:37:55
NME

Base Information

Drug NameSyk kinase silencer (ZaBeCor)
Drug Alias NameExcellair
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionSpleen tyrosine kinase inhibitorsRNA interference
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsInflammationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZabecor PharmaceuticalsUniversity Of Pennsylvania
Active IndicationsN/A
Inactive IndicationsInflammationAsthma

Other Information

ATC CodeN/A
Related LinksN/A